Mechanistic insights into the antifibrotic activity of aliskiren in the kidney

Excess nicotinamide inhibits methylation-mediated degradation of catecholamines in normotensives and hypertensives

(2011) Wu-Ping Sun et al.   HYPERTENSION RESEARCH

Aliskiren Ameliorates Renal Inflammation and Fibrosis Induced by Unilateral Ureteral Obstruction in Mice

(2011) Dae Eun Choi et al.   JOURNAL OF UROLOGY

Renal Protective Effects of Aliskiren Beyond Its Antihypertensive Property in a Mouse Model of Progressive Fibrosis

(2010) O. Gross et al.   AMERICAN JOURNAL OF HYPERTENSION

Application of Direct Renin Inhibition to Chronic Kidney Disease

(2010) Christian W. Mende   CARDIOVASCULAR DRUGS AND THERAPY

Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro

(2010) Kazal Boron Biswas et al.   HYPERTENSION RESEARCH

New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease

(2010) David L Feldman   HYPERTENSION RESEARCH

Mechanisms of Tubulointerstitial Fibrosis

(2010) M. Zeisberg et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Aliskiren Enhances the Protective Effects of Valsartan Against Cardiovascular and Renal Injury in Endothelial Nitric Oxide Synthase–Deficient Mice

(2009) Eiichiro Yamamoto et al.   HYPERTENSION

Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats

(2008) David L. Feldman et al.   HYPERTENSION

Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskiren

(2008) Wendy W Batenburg et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM